SIMG
IONS icon

Sonora Investment Management Group’s Ionis Pharmaceuticals IONS Stock Holding History

Sonora Investment Management Group’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$11.1M Buy
169,808
+6,636
+4% +$324K 0.79% 43
2025
Q2 		$6.45M Buy
163,172
+9,025
+6% +$295K 0.48% 59
2025
Q1 		$4.65M Buy
154,147
+5,371
+4% +$176K 0.37% 69
2024
Q4 		$5.2M Sell
148,776
-4,399
-3% -$164K 0.4% 66
2024
Q3 		$6.14M Buy
153,175
+2,361
+2% +$110K 0.45% 66
2024
Q2 		$6.54M Hold
150,814
– – 0.51% 66
2024
Q1 		$6.54M Buy
150,814
+1,476
+1% +$70.4K 0.51% 66
2023
Q4 		$7.56M Buy
149,338
+888
+0.6% +$42.5K 0.61% 60
2023
Q3 		$6.73M Sell
148,450
-1,755
-1% -$72.4K 0.58% 63
2023
Q2 		$6.16M Sell
150,205
-2,628
-2% -$101K 0.52% 70
2023
Q1 		$5.46M Sell
152,833
-3,282
-2% -$123K 0.48% 78
2022
Q4 		$5.9M Sell
156,115
-908
-0.6% -$38.2K 0.54% 77
2022
Q3 		$5.81M Buy
157,023
+700
+0.4% +$29.5K 0.75% 52
2022
Q2 		$5.79M Sell
156,323
-938
-0.6% -$35.4K 0.55% 70
2022
Q1 		$5.83M Buy
157,261
+471
+0.3% +$15.4K 0.66% 55
2021
Q4 		$4.77M Buy
+156,790
New +$4.94M 0.55% 62

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sonora Investment Management Group's IONS Position: Q3 2025 in Review

Sonora Investment Management Group increased its Ionis Pharmaceuticals (IONS) stake by 4.1% in Q3 2025, buying an estimated $324K and bringing the position to 169,808 shares worth $11.1M. The position accounts for 0.79% of the portfolio, ranked #43.

Sonora Investment Management Group first reported a position in IONS in Q4 2021 and has held it in 16 quarters since. 436 funds tracked by Wall St. Rank hold IONS as of Q3 2025.

  • Sonora Investment Management Group held 169,808 shares of Ionis Pharmaceuticals worth $11.1M as of Q3 2025.
  • Sonora Investment Management Group bought 6,636 Ionis Pharmaceuticals shares in Q3 2025, an estimated $324K.
  • Ionis Pharmaceuticals made up 0.79% of Sonora Investment Management Group's portfolio in Q3 2025, its #43 holding.
  • Sonora Investment Management Group first reported a position in Ionis Pharmaceuticals in Q4 2021 and has held it in 16 quarters since.
  • 436 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2025.

Based on Sonora Investment Management Group's 13F filing for Q3 2025, filed 7 Oct 2025.